Knee Hyaluronic Acid Injection Market Report 2025 (Global Edition)

Global Knee Hyaluronic Acid Injection Market Report 2025 Market Size Split by Indication Outlook: (Osteoarthritis, Rheumatoid Arthritis, Other Indications), by Route of Administration Outlook: (Intra-...

Knee Hyaluronic Acid Injection Market Report Description

We have various report editions of Knee Hyaluronic Acid Injection Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Knee Hyaluronic Acid Injection Market Insights Video

Competitive Landscape of the Knee Hyaluronic Acid Injection Market

The market for knee hyaluronic acid (HA) injections is extremely competitive, with many well-established firms and up-and-coming businesses spearheading innovation. With a variety of single- and multi-injection products, major companies include Sanofi, Fidia Farmaceutici, Seikagaku Corporation, and Zimmer Biomet. Product effectiveness, cost, and developments in HA formulations, including cross-linked and extended-release versions, are the main areas of competition. Through strategic partnerships and R&D investments, businesses are diversifying their holdings. In emerging markets, regional businesses increase the level of competition by offering more affordable options. Regulatory approvals, reimbursement practices, and healthcare providers' acceptance of individualized treatment approaches all influence market dynamics.

In November 2024, Muse, a sophisticated AI-powered platform created to expedite and enhance drug development by improving patient recruitment for clinical trials, was unveiled by Formation Bio, OpenAI, and Sanofi. Muse is the first product of the three businesses' partnership, which intends to speed up medication research and, eventually, the delivery of ground-breaking cures to patients by combining their pharmaceutical expertise and AI models. (Source: https://www.prnewswire.com/news-releases/formation-bio-collaborates-with-sanofi-and-openai-to-introduce-muse-a-first-of-its-kind-ai-tool-to-accelerate-patient-recruitment-in-drug-development-302301958.html ) In May 2024, A co-exclusive licensing deal has been announced by Sanofi and Novavax to jointly market the COVID-19 vaccine and create innovative flu-COVID-19 combo vaccines. (Source: https://www.globenewswire.com/news-release/2024/05/10/2879379/0/en/Press-Release-Sanofi-and-Novavax-announce-co-exclusive-licensing-agreement-to-co-commercialize-COVID-19-vaccine-and-develop-novel-flu-COVID-19-combination-vaccines.html ) In May 2020, OrthogenRx, Inc., a medical device company focused on the discovery and marketing of treatments for knee pain caused by osteoarthritis (OA), announced new price choices for the TriVisc Direct Purchase. (Source: https://www.biospace.com/orthogenrx-announces-new-trivisc-patient-programs )

Top Companies Market Share in Knee Hyaluronic Acid Injection Industry: (In no particular order of Rank)

• Anika Therapeutics Inc. (DePuy Synthes Inc.)
• Chugai Pharmaceuticals Co. Ltd.
• Ferring B.V.
• Fidia Farmaceutici S.p.A
• Hanmi Pharm Co. Ltd. (Teva Pharmaceuticals Industries Ltd.)
• Institut Biochimique SA (Bioventus LLC)
• Meiji Seika Pharma Co. Ltd. (OrthogenRx)
• Sanofi
• Seikagaku Corporation
• Viatrus Inc.
• Zimmer Biomet
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Knee Hyaluronic Acid Injection Market

Which Region Dominates the Knee Hyaluronic Acid Injection Market in 2024?

According to Cognitive Market Research, North America currently dominates the Knee Hyaluronic Acid Injection Markets, and the region is expected to have significant growth during the projected period. In North America, osteoarthritis is becoming more common in older and obese people, which is driving up demand for knee hyaluronic acid (HA) injections. Adoption is fueled by patients' growing preference for non-surgical methods of pain management and mobility enhancement. Technological developments that improve convenience and efficacy, like single-injection and cross-linked HA formulations, propel market expansion.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The Asia-Pacific (APAC) region's aging population, rising osteoarthritis prevalence, and easier access to healthcare are all contributing to the demand for knee hyaluronic acid (HA) injections. Adoption and affordability are fueled by rising middle-class populations and economic growth. Additionally, the availability of affordable local HA products and increased awareness of non-surgical therapies support market growth in this area.

The current report Scope analyzes Knee Hyaluronic Acid Injection Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Knee Hyaluronic Acid Injection Market Analysis

According to Cognitive Market Research, the global Knee Hyaluronic Acid Injection Market size was estimated at USD 2152.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 861.00 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Knee Hyaluronic Acid Injection Market with a market size of USD 679.33 million in 2024 and is projected to grow at a CAGR of 3.5% during the forecast period. Advanced formulations, non-surgical choices, and the high frequency of osteoarthritis in the United States are driving demand for knee hyaluronic acid injections.
• The Canada Knee Hyaluronic Acid Injection Market had a market share of USD 103.32 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. The aging population and inclination for non-surgical osteoarthritis therapies are driving up demand for knee hyaluronic acid injections in Canada.
• The Mexico Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 78.35 million in 2024.

Europe Knee Hyaluronic Acid Injection Market Analysis

According to Cognitive Market Research, the global Knee Hyaluronic Acid Injection Market size was estimated at USD 2152.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 645.75 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.0% from 2024 to 2031.

• The United Kingdom Knee Hyaluronic Acid Injection Market had a market share of USD 108.49 million in 2024 and is projected to grow at a CAGR of 4.8% during the forecast period. The demand for knee hyaluronic acid injections in the UK is driven by an increase in osteoarthritis cases and a preference for non-surgical therapies.
• The France Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 59.41 million in 2024.
• According to Cognitive Market Research, the German Knee Hyaluronic Acid Injection Market size was valued at USD 127.86 million in 2024 and is projected to grow at a CAGR of 4.2% during the forecast period. In Germany, An aging population and improved healthcare infrastructure are the main drivers of the need for knee hyaluronic acid injections.
• The Italy Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 3.4% during the forecast period, with a market size of USD 55.53 million in 2024.
• The Russia Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 3.0% during the forecast period, with a market size of USD 100.09 million in 2024.
• The Spain Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 3.1% during the forecast period with a market size of USD 52.95 million in 2024
• The Luxembourg Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 4.1% during the forecast period, with a market size of USD 20.02 million in 2024.
• The Portugal Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD 13.56 million in 2024.
• The Greece Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 7.75 million in 2024.
• The Rest of Europe's Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 2.7% during the forecast period, with a market size of USD 100.09 million in 2024.

Asia Pacific Knee Hyaluronic Acid Injection Market Analysis

According to Cognitive Market Research, the global Knee Hyaluronic Acid Injection Market size was estimated at USD 2152.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 495.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.

• According to Cognitive Market Research, the China Knee Hyaluronic Acid Injection Market size was valued at USD 222.78 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. Rising osteoarthritis prevalence, an older population, and increased awareness of non-surgical treatments all drive demand for knee hyaluronic acid injections.
• The Japan Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 68.32 million in 2024.
• The India Knee Hyaluronic Acid Injection Market had a market share of USD 59.41 million in 2024 and is projected to grow at a CAGR of 9.3% during the forecast period. Demand for knee hyaluronic acid injections is driven by an increase in osteoarthritis patients, an aging population, and a preference for cost-effective, non-surgical treatments.
• The South Korean Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 49.51 million in 2024.
• The Australian Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 25.74 million in 2024.
• The South East Asia Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 34.16 million in 2024.
• The Rest of Asia Pacific Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 35.15 million in 2024.

South America Knee Hyaluronic Acid Injection Market Analysis

According to Cognitive Market Research, the global Knee Hyaluronic Acid Injection Market size was estimated at USD 2152.5 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 107.63 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Knee Hyaluronic Acid Injection Market size was valued at USD 46.06 million in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period. Increased osteoarthritis cases fuel demand for knee HA injections.
• Argentina's Knee Hyaluronic Acid Injection Market had a market share of USD 18.08 million in 2024 and is projected to grow at a CAGR of 5.8% during the forecast period. Argentina's rising personal disposable income.
• Colombia Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 9.58 million in 2024.
• Peru Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 5.1% during the forecast period, with a market size of USD 8.83 million in 2024.
• Chile Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 7.75 million in 2024.
• The Rest of Latin America's Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 17.33 million in 2024.

Middle East Knee Hyaluronic Acid Injection Market Analysis

According to Cognitive Market Research, the global Knee Hyaluronic Acid Injection Market size was estimated at USD 2152.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 43.05 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031..

• The GCC Countries Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 18.43 million in 2024. Rising osteoarthritis prevalence drives the demand for knee HA injections.
• The Egypt Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 4.52 million in 2024.
• The South Africa Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 6.80 million in 2024. Rising osteoarthritis cases and increased awareness of non-surgical therapy options are boosting demand for knee hyaluronic acid injections.
• The Turkey Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 3.70 million in 2024.
• The Nigeria Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 4.52 million in 2024.
• The Rest of the MEA Knee Hyaluronic Acid Injection Market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 5.08 million in 2024.

Knee Hyaluronic Acid Injection Market Analysis

How are Segments Performing in the Global Knee Hyaluronic Acid Injection Market?

Knee Hyaluronic Acid Injection Market Indication Segment Analysis

According to Cognitive Market Research, Osteoarthritis are likely to dominate the Knee Hyaluronic Acid Injection Market over the forecast period. The increasing incidence of osteoarthritis, a degenerative joint disease that typically affects the elderly and obese, is directly related to the need for knee hyaluronic acid (HA) injections. Patients seek effective non-surgical therapies for osteoarthritis as it worsens, causing joint pain, stiffness, and decreased mobility. Injections of HA, which lubricate and cushion the knee joint by simulating natural synovial fluid, are becoming more and more popular for treating early-to-moderate osteoarthritis symptoms. Improvements in HA formulations, such as single-injection choices, attractive reimbursement rules, and increased knowledge of non-invasive therapies all contribute to this need. These elements make HA injections a crucial therapeutic choice.

The Rheumatoid Arthritis is the fastest-growing segment in the Knee Hyaluronic Acid Injection Market. Compared to osteoarthritis, rheumatoid arthritis (RA) patients have a comparatively low need for knee hyaluronic acid (HA) injections. While HA injections are intended to address mechanical problems like lubrication and cushioning in degenerative joint diseases, RA is an autoimmune disease that primarily causes inflammation in the joints. However, HA injections may be utilized as an adjuvant treatment to enhance joint function and lessen pain in certain RA cases, especially when inflammation coexists with cartilage deterioration. Although demand may be somewhat increased by raising awareness of HA injections and their off-label usage in specific RA situations, anti-inflammatory and disease-modifying treatments continue to play a more important role.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Knee Hyaluronic Acid Injection Industry. Request a Free Sample PDF!

Knee Hyaluronic Acid Injection Market Route of Administration Segment Analysis

According to Cognitive Market Research, the Intra-articular Injection segment holds the largest share of the market. Because knee osteoarthritis is becoming more common and non-surgical treatments are becoming more popular, there is a growing need for intra-articular hyaluronic acid (HA) injections in the knee market. By directly delivering the medication to the knee joint, intra-articular HA injections offer focused pain, stiffness, and inflammation alleviation. They delay the need for invasive operations like knee replacements, increase mobility, and improve joint lubrication. Demand has been greatly increased by the growing need for less intrusive solutions as well as developments in HA formulations, such as single-injection and extended-release therapies. Intra-articular HA injection use is further supported by advantageous reimbursement policies and raised patient awareness.

In the Knee Hyaluronic Acid Injection Market, the Other Routes has been expanding at a rapid pace. Although intra-articular injections continue to be the most common method of treating knee hyaluronic acid (HA), other methods are progressively attracting market interest. These include intra-synovial and peri-articular injections, which are intended to deliver HA directly to the synovial membrane or adjacent tissues around the joint. With fewer adverse effects, these techniques might offer focused pain alleviation and decreased inflammation. However, because of known techniques and a lack of clinical proof, their demand is lower than that of intra-articular injections. Nevertheless, as new formulations and methods are developed, increasing study and interest in extending HA delivery pathways may propel future industry developments.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Knee Hyaluronic Acid Injection Product Type Outlook: Segment Analysis

Knee Hyaluronic Acid Injection Market Product Type Segment Analysis

According to Cognitive Market Research, The Biopharmaceuticals segment holds the largest market share. As more sophisticated biologic-based treatments being investigated for joint health, the market for knee hyaluronic acid (HA) injections is seeing an increase in demand for biopharmaceuticals. Traditional HA treatments are supplemented by biopharmaceuticals, such as improved HA formulations and injections made from biological materials like platelet-rich plasma (PRP) and stem cell therapies. By encouraging cartilage regeneration and lowering inflammation, these biologics seek to provide increased efficacy. Although conventional HA injections are still the most common treatment for knee osteoarthritis, growing interest in biologics indicates a move toward more regenerative methods. The market for knee HA injections is anticipated to change in the future due to this increased interest, which is being fueled by developments in biotechnology and clinical research.

In the Knee Hyaluronic Acid Injection Market, the rapidly growing sector is the Generic Medications category. Due to their cost and growing patient and healthcare provider adoption, generic drugs are becoming more and more popular in the knee hyaluronic acid (HA) injection market. Generic substitutes provide affordable options without sacrificing the effectiveness of treatment when the patents on branded HA products expire. These generic HA injections are especially appealing in areas where insurance coverage is scarce or in markets where consumers are price conscious. The market is expanding as a result of the availability of generic alternatives, which provide greater access to joint pain treatment. Generic HA injections are anticipated to become more in demand as healthcare systems continue to prioritize cost reduction, making them a crucial part of the market's growth.

• Biopharmaceuticals
• Generic Medications

Knee Hyaluronic Acid Injection Molecular Weight Outlook: Segment Analysis

Knee Hyaluronic Acid Injection Market Molecular Weight Segment Analysis

According to Cognitive Market Research, the Low Molecular Weight segment dominates the market. Due to its improved tissue penetration and faster start of action than high molecular weight formulations, low molecular weight hyaluronic acid (LMW-HA) injections are becoming more and more popular in the knee market. LMW-HA injections are a desirable therapy option for people with osteoarthritis in their knees because they provide better joint lubrication, less pain, and more mobility. For greater effectiveness, they are frequently used in conjunction with other therapies. Additionally, improvements in product formulations that enhance patient outcomes and decrease the frequency of injections are driving demand. LMW-HA injections are becoming more and more well-liked as a good substitute for conventional therapies as patients look for efficient, less invasive procedures.

High Molecular Weight is projected to be the fastest-growing segment in the Knee Hyaluronic Acid Injection Market. great molecular weight hyaluronic acid (HMW-HA) injections continue to be in great demand in the knee market because of their capacity to enhance cartilage protection and offer long-lasting joint lubrication. By replenishing synovial fluid in the joint, lowering discomfort, and increasing mobility, HMW-HA formulations—which are renowned for their exceptional viscosity—are very helpful in treating osteoarthritis in the knee. Compared to low molecular weight alternatives, these injections usually require fewer treatments and have longer-lasting benefits; nevertheless, their higher cost may restrict accessibility. However, demand is still being driven by the effectiveness and long-lasting effects of HMW-HA injections, especially among patients looking for long-term pain management treatments.

• Low Molecular Weight
• Medium Molecular Weight
• High Molecular Weight

Knee Hyaluronic Acid Injection Product Form Outlook: Segment Analysis

Knee Hyaluronic Acid Injection Market Product Form Segment Analysis

According to Cognitive Market Research, the Viscosupplementation Injections segment dominates the market. Due to its efficacy in treating osteoarthritis in the knee, viscosupplementation injections are becoming more and more popular in the knee hyaluronic acid (HA) market. In order to restore synovial fluid, lower friction, increase joint mobility, and significantly alleviate pain, viscosupplementation entails injecting HA directly into the joint. Patients looking for alternatives to knee replacement surgery are especially drawn to this minimally invasive, non-surgical procedure. The need for viscosupplementation injections is being further fueled by the increased preference for non-invasive therapies as well as developments in HA formulations, including single-injection and extended-release solutions. It is anticipated that viscosupplementation will continue to gain popularity as more people become aware of its advantages.

Combinational Products is projected to be the fastest-growing segment in the Knee Hyaluronic Acid Injection Market. In the market for knee hyaluronic acid (HA) injections, combinational products are becoming more and more popular as medical professionals look for more comprehensive, efficient treatments for osteoarthritis in the knee. To improve pain management, lower inflammation, and encourage cartilage repair, these medicines mix HA with additional therapeutic agents such growth factors, platelet-rich plasma (PRP), or corticosteroids. By treating several facets of osteoarthritis, from joint regeneration to symptom management, combinational therapies provide patients with better results. The market for these combination solutions is anticipated to expand as patients and healthcare professionals seek for more all-encompassing treatment choices, providing a cutting-edge approach to the management of osteoarthritis in the knee.

• Viscosupplementation Injections
• Combinational Products

Knee Hyaluronic Acid Injection Distribution Channel Outlook: Segment Analysis

Knee Hyaluronic Acid Injection Market Distribution Channel Segment Analysis

According to Cognitive Market Research, the Hospital Pharmacies segment dominates the market. Because hospital pharmacists offer specialist treatments for knee osteoarthritis, there is a considerable demand for knee hyaluronic acid (HA) injections. In order to ensure correct dosing and patient monitoring, hospital pharmacists provide a controlled setting for delivering these injections. The increasing number of hospital-based therapies for long-term joint disorders, which frequently include HA injections as a component of all-inclusive pain management programs, supports the need. Direct supplier partnerships also help hospitals by guaranteeing a consistent supply of high-quality HA products. Hospital pharmacies are essential to increase access to HA injectable therapies as non-surgical treatments get more attention.

Retail Pharmacies are projected to be the fastest-growing segment in the Knee Hyaluronic Acid Injection Market. Because more patients want easier access to therapies, there is an increasing demand for knee hyaluronic acid (HA) injections from retail pharmacies. Patients can manage their osteoarthritis pain more autonomously because to retail pharmacies' improved access to HA injectable products, particularly for those with prescription coverage. The growing use of outpatient therapies and the expansion of both prescription and over-the-counter HA injectable options in retail settings provide credence to this trend. Additionally, as non-surgical pain management gains popularity, retail pharmacies are essential in increasing access to reasonably priced and efficient knee HA therapies.

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion